Evidence map›Paper›PMID 37076850›Full record

ArticleCardiovascular diabetology2023

Triglyceride-glucose index, symptomatic intracranial artery stenosis and recurrence risk in minor stroke patients with hypertension.

Yongle Wang, Tingting Liu, Yanan Li, Kaili Zhang, Haimei Fan, Jing Ren, Juan Li, Yali Li, Xinyi Li, Xuemei Wu and 10 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Cardiovascular diabetology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 1 country.

Yongle Wang *Department of Neurology, First Hospital of Shanxi Medical University, No. 85, Jiefangnan Street, Yingze District, Taiyuan, Shanxi, China.
Tingting Liu *Department of Neurology, First Hospital of Shanxi Medical University, No. 85, Jiefangnan Street, Yingze District, Taiyuan, Shanxi, China.
Yanan LiDepartment of Neurology, First Hospital of Shanxi Medical University, No. 85, Jiefangnan Street, Yingze District, Taiyuan, Shanxi, China.
Kaili ZhangDepartment of Neurology, Shanxi Bethune Hospital, Tongji Shanxi Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Haimei FanDepartment of Neurology, Sixth Hospital of Shanxi Medical University (General Hospital of Tisco), Taiyuan, Shanxi, China.
Jing RenShanxi Province Cardiovascular Disease Hospital, Taiyuan, Shanxi, China.
Juan LiCangzhou Central Hospital, Cangzhou, Hebei, China.
Yali LiClinical College, Shanxi Medical University, No. 58, Xinjiannan Street, Yingze District, Taiyuan, Shanxi, China.
Xinyi LiDepartment of Neurology, Shanxi Bethune Hospital, Tongji Shanxi Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Xuemei WuDepartment of Neurology, Sixth Hospital of Shanxi Medical University (General Hospital of Tisco), Taiyuan, Shanxi, China.
Junhui WangYanhu Branch First Hospital of Shanxi Medical University, Yuncheng, Shanxi, China.
Lixi XueYanhu Branch First Hospital of Shanxi Medical University, Yuncheng, Shanxi, China.
Xiaolei GaoTaiyuan Wanbailin District Medical Group Central Hospital, Taiyuan, Shanxi, China.
Yuping YanTaiyuan Wanbailin District Medical Group Central Hospital, Taiyuan, Shanxi, China.
Gaimei LiChina Railway 17th Bureau Group Company Central Hospital, Shanxi, Taiyuan, China.
Qingping LiuChina Railway 17th Bureau Group Company Central Hospital, Shanxi, Taiyuan, China.
Wenhua NiuFirst People's Hospital of JIN ZHONG, Jinzhong, Shanxi, China.
Wenxian DuFirst People's Hospital of JIN ZHONG, Jinzhong, Shanxi, China.
Yuting LiuShanxi Province Cardiovascular Disease Hospital, Taiyuan, Shanxi, China.
Xiaoyuan NiuDepartment of Neurology, First Hospital of Shanxi Medical University, No. 85, Jiefangnan Street, Yingze District, Taiyuan, Shanxi, China. niuxiaoyuan1958@163.com.
First Hospital of Shanxi Medical University · CNShanxi Medical University · CNChina Railway Group (China) · CNShanxi Cardiovascular Hospital · CNTaiyuan Central Hospital · CNCangzhou Central Hospital · CNShanxi Academy of Medical Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe triglyceride-glucose (TyG) index, a simple measure of insulin resistance, is associated with intracranial atherosclerosis (ICAS) and stroke. In hypertensive populations, this association may be pronounced. The aim was to investigate the relationship between TyG and symptomatic intracranial atherosclerosis (sICAS) and recurrence risk in ischemic stroke patients with hypertension.

methodsThis prospective, multicenter cohort study included patients with acute minor ischemic stroke with a preadmission diagnosis of hypertension from September 2019 to November 2021 with a 3-month follow-up. The presence of sICAS was determined by a combination of clinical manifestations, the location of the infarction, and the corresponding artery with moderate-to-severe stenosis. ICAS burden was determined by the degree and number of ICAS occurrences. Fasting blood glucose (FBG) and triglyceride (TG) were measured to calculate TyG. The main outcome was ischemic stroke recurrence during the 90-day follow-up. Multivariate regression models were used to explore the association of TyG, sICAS, and ICAS burden with stroke recurrence.

resultsThere were 1281 patients with a mean age of 61.6 ± 11.6 years; 70.1% were male, and 26.4% were diagnosed with sICAS. There were 117 patients who experienced stroke recurrence during follow-up. Patients were categorized according to quartiles of TyG. After adjusting for confounders, the risk of sICAS was greater (OR 1.59, 95% CI 1.04-2.43, p = 0.033) and the risk of stroke recurrence was significantly higher (HR 2.02, 95% CI 1.07-3.84, p = 0.025) in the fourth TyG quartile than in the first quartile. The restricted cubic spline (RCS) plot revealed a linear relationship between TyG and sICAS, and the threshold value for TyG was 8.4. Patients were then dichotomized into low and high TyG groups by the threshold. Patients with high TyG combined with sICAS had a higher risk of recurrence (HR 2.54, 95% CI 1.39-4.65) than patients with low TyG without sICAS. An interaction effect on stroke recurrence between TyG and sICAS was found (p = 0.043).

conclusionTyG is a significant risk factor for sICAS in hypertensive patients, and there is a synergistic effect of sICAS and higher TyG on ischemic stroke recurrence. TRIAL REGISTRATION NUMBER: The study was registered on 16 August 2019 at https://www.chictr.org.cn/showprojen.aspx?proj=41160 (No. ChiCTR1900025214).

Indexed as

HypertensionIntracranial ArteriosclerosisIschemic StrokeStrokeAgedArteriesBiomarkersBlood GlucoseCohort StudiesConstriction, PathologicFemaleGlucoseHumansMaleMiddle AgedProspective StudiesBiomarkersBlood GlucoseGlucoseTriglyceridesInsulin resistanceStroke recurrenceSymptomatic intracranial atherosclerosisTriglyceride-glucose index

Identifiers

PMID37076850
PMCPMC10114394
OpenAlexW4366581020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.